Cirrhosis after pancreaticoduodenectomy for pancreatic cancer  

作　　者：Rui Su Hong-Na Liu Yu-Bo Wang Yun Bai 

机构地区：[1]Graduate Academy,Hebei Medical University,Shijiazhuang 050017,China [2]Department of Geriatric Gastroenterology,Hebei General Hospital,Shijiazhuang 050000,China [3]Graduate Academy,North China University of Science and Technology,Tangshan 063000,China

出　　处：《Hepatobiliary & Pancreatic Diseases International》2025年第2期232-236,共5页国际肝胆胰疾病杂志(英文版)

摘　　要：To the Editor:Nonalcoholic fatty liver disease(NAFLD)is a clinicopathological syndrome characterized by excessive intracellular lipid accumulation in hepatocytes,not attributed to alcohol,viral infections,or other well-defined causes of hepatic injury.The spectrum of NAFLD encompasses nonalcoholic hepatic steatosis,nonalcoholic steatohepatitis(NASH),and associated conditions like hepatic fibrosis,cirrhosis,and hepatocellular carcinoma.NAFLD is associated with various factors,including obesity,type 2 diabetes mellitus,dyslipidemia,and hypertension.Several studies have also highlighted pancreaticoduodenectomy(PD)as a potential cause of NAFLD[1-3].The type of fatty liver disease induced by PD is etiologically linked to impaired exocrine pancreatic function[3].

关 键 词：IMPAIRED NAFLD HEPATIC 

分 类 号：R57[医药卫生—消化系统]